Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.

Scott V Joy

TitleAffiliate - PSL
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gallagher P, King HA, Haga SB, Orlando LA, Joy SV, Trujillo GM, Scott WM, Bembe M, Creighton DL, Cho AH, Ginsburg GS, Vorderstrasse A. Patient beliefs and behaviors about genomic risk for type 2 diabetes: implications for prevention. J Health Commun. 2015; 20(6):728-35. PMID: 25844569.
      View in: PubMed
    2. Siddiqui M, Joy S, Elwell D, Anderson GF. The National Commission on Physician Payment Reform: recalibrating fee-for-service and transitioning to fixed payment models. J Gen Intern Med. 2014 May; 29(5):700-2. PMID: 24573711.
      View in: PubMed
    3. Li JH, Joy SV, Haga SB, Orlando LA, Kraus WE, Ginsburg GS, Voora D. Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients. J Pers Med. 2014 Mar 27; 4(2):147-62. PMID: 25563221.
      View in: PubMed
    4. Cho AH, Killeya-Jones LA, O'Daniel JM, Kawamoto K, Gallagher P, Haga S, Lucas JE, Trujillo GM, Joy SV, Ginsburg GS. Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design. BMC Health Serv Res. 2012 Jan 18; 12:16. PMID: 22257365.
      View in: PubMed
    5. Kawamoto K, Orlando LA, Voora D, Lobach DF, Joy S, Cho A, Ginsburg GS. Evaluation of the PharmGKB knowledge base as a resource for efficiently assessing the clinical validity and utility of pharmacogenetic assays. AMIA Annu Symp Proc. 2009 Nov 14; 2009:307-11. PMID: 20351870.
      View in: PubMed
    6. Joy SV. Clinical pearls and strategies to optimize patient outcomes. Diabetes Educ. 2008 May-Jun; 34 Suppl 3:54S-59S. PMID: 18525065.
      View in: PubMed
    7. Joy SV. Clinical pearls and strategies to optimize patient outcomes. J Am Acad Nurse Pract. 2007; 19(11 Suppl 1):15-20. PMID: 18341244.
      View in: PubMed
    8. Taulien CA, Joy SV. Ruboxistaurin. Drugs Today (Barc). 2006 Sep; 42(9):577-85. PMID: 17028667.
      View in: PubMed
    9. Joy SV, Scates AC, Bearelly S, Dar M, Taulien CA, Goebel JA, Cooney MJ. Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications. Ann Pharmacother. 2005 Oct; 39(10):1693-9. PMID: 16160002.
      View in: PubMed
    10. Joy SV, Rodgers PT, Scates AC. Incretin mimetics as emerging treatments for type 2 diabetes. Ann Pharmacother. 2005 Jan; 39(1):110-8. PMID: 15562141.
      View in: PubMed
    11. Ressler IB, Cash J, McNeill D, Joy S, Rosoff PM. Continued parental attendance at a clinic for adult survivors of childhood cancer. J Pediatr Hematol Oncol. 2003 Nov; 25(11):868-73. PMID: 14608196.
      View in: PubMed
    Joy's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description

    Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)